Notify me when RICHARD S. LINDAHL files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | EVP, Chief Financial Officer | $2,798,371 | 15 Oct 2025 | ||
| CMPX | Compass Therapeutics, Inc. | Director | 11 Feb 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|